Literature DB >> 28490990

Management of liver cancer. The Surgeon's point of view.

Pierre Rabinel1, Damien Dousse1, Fabrice Muscari1, Bertrand Suc1.   

Abstract

During the last twenty years, a huge progress has been achieved in the treatment of liver cancer and recent strategies include interventional radiology, chemotherapy regimens and surgery. Meanwhile, Stereotactic Body Radiation Therapy (SRBT) has developed in the treatment of all organs with millimetre accuracy, very few side effects and a high control rate. So, SRBT has become a therapeutic weapon in his own right in liver tumour treatment. Many publications have reported encouraging results in colorectal liver metastasis, hepatocellular carcinoma on cirrhosis and peripheric cholangiocarcinoma. It is important that radiation therapists involve systematic multidisciplinary "liver tumour" meetings to discuss therapeutic indications and initiate treatments quickly.

Entities:  

Keywords:  Cholangiocarcinoma; Colorectal metastasis; Hepatocellular carcinoma; Liver cancer; Radiotherapy

Year:  2017        PMID: 28490990      PMCID: PMC5411896          DOI: 10.1016/j.rpor.2017.02.001

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  30 in total

1.  Combined vascular resection and reconstruction during hepatobiliary and pancreatic cancer surgery.

Authors:  M Miyazaki
Journal:  Br J Surg       Date:  2014-08-21       Impact factor: 6.939

2.  Adjuvant stereotactic body radiotherapy following transarterial chemoembolization in patients with non-resectable hepatocellular carcinoma tumours of ≥ 3 cm.

Authors:  Rojymon Jacob; Falynn Turley; David T Redden; Souheil Saddekni; Ahmed K A Aal; Kimberly Keene; Eddy Yang; Jessica Zarzour; David Bolus; J Kevin Smith; Stephen Gray; Jared White; Devin E Eckhoff; Derek A DuBay
Journal:  HPB (Oxford)       Date:  2014-09-04       Impact factor: 3.647

3.  Remnant liver volume to body weight ratio > or =0.5%: A new cut-off to estimate postoperative risks after extended resection in noncirrhotic liver.

Authors:  Stéphanie Truant; Olivier Oberlin; Géraldine Sergent; Gilles Lebuffe; Luc Gambiez; Olivier Ernst; François-René Pruvot
Journal:  J Am Coll Surg       Date:  2006-11-16       Impact factor: 6.113

Review 4.  Percutaneous microwave ablation vs radiofrequency ablation in the treatment of hepatocellular carcinoma.

Authors:  Loukia S Poulou; Evanthia Botsa; Ioanna Thanou; Panayiotis D Ziakas; Loukas Thanos
Journal:  World J Hepatol       Date:  2015-05-18

5.  Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings.

Authors:  Andreas A Schnitzbauer; Sven A Lang; Holger Goessmann; Silvio Nadalin; Janine Baumgart; Stefan A Farkas; Stefan Fichtner-Feigl; Thomas Lorf; Armin Goralcyk; Rüdiger Hörbelt; Alexander Kroemer; Martin Loss; Petra Rümmele; Marcus N Scherer; Winfried Padberg; Alfred Königsrainer; Hauke Lang; Aiman Obed; Hans J Schlitt
Journal:  Ann Surg       Date:  2012-03       Impact factor: 12.969

6.  Combined first-stage hepatectomy and colorectal resection in a two-stage hepatectomy strategy for bilobar synchronous liver metastases.

Authors:  M Karoui; L Vigano; P Goyer; A Ferrero; A Luciani; M Aglietta; C Delbaldo; S Cirillo; L Capussotti; D Cherqui
Journal:  Br J Surg       Date:  2010-09       Impact factor: 6.939

7.  Transcatheter arterial chemoembolization followed by immediate radiofrequency ablation for large solitary hepatocellular carcinomas.

Authors:  Zhi-Jun Wang; Mao-Qiang Wang; Feng Duan; Peng Song; Feng-Yong Liu; Zhong-Fei Chang; Yan Wang; Jie-Yu Yan; Kai Li
Journal:  World J Gastroenterol       Date:  2013-07-14       Impact factor: 5.742

8.  Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma.

Authors:  Regina V Tse; Maria Hawkins; Gina Lockwood; John J Kim; Bernard Cummings; Jennifer Knox; Morris Sherman; Laura A Dawson
Journal:  J Clin Oncol       Date:  2008-01-02       Impact factor: 44.544

9.  Portal vein embolization before right hepatectomy: prospective clinical trial.

Authors:  Olivier Farges; Jacques Belghiti; Reza Kianmanesh; Jean Marc Regimbeau; Roberto Santoro; Valérie Vilgrain; Alban Denys; Alain Sauvanet
Journal:  Ann Surg       Date:  2003-02       Impact factor: 12.969

Review 10.  [Stereotactic body radiation therapy in the management of liver tumours].

Authors:  J Jacob; F Nguyen; E Deutsch; F Mornex
Journal:  Cancer Radiother       Date:  2014-09-05       Impact factor: 1.018

View more
  5 in total

1.  Editorial.

Authors:  Miquel Macià; Carmen Llacer-Moscardo
Journal:  Rep Pract Oncol Radiother       Date:  2016-10-15

2.  Hypericin Exerts Detrimental Effect on Huh-7 As a Delegacy of Hepatocellular Carcinoma: A P53 Dependent Pathway.

Authors:  Maedeh Olya; Hamid Zaferani Arani; Amirhossein Shekarriz; Amirhossein Zabolian; Hadi Zare Marzouni; Hoda Aryan; Mohammad Hoseinian; Mohammad Amin Javidi; Hesam Adin Atashi
Journal:  Galen Med J       Date:  2020-12-28

3.  MicroRNA‑34a inhibits liver cancer cell growth by reprogramming glucose metabolism.

Authors:  Hai-Feng Zhang; Yi-Cheng Wang; Yi-Di Han
Journal:  Mol Med Rep       Date:  2018-01-09       Impact factor: 2.952

4.  Enhancing the efficacy of albendazole for liver cancer treatment using mesoporous silica nanoparticles: an in vitro study.

Authors:  Mohsen Ghaferi; Warda Zahra; Azim Akbarzadeh; Hasan Ebrahimi Shahmabadi; Seyed Ebrahim Alavi
Journal:  EXCLI J       Date:  2022-01-11       Impact factor: 4.068

5.  Partial hepatectomy enhances the growth of CC531 rat colorectal cancer cells both in vitro and in vivo.

Authors:  Borja Herrero de la Parte; Mikel González-Arribas; Iñaki Diaz-Sanz; Teodoro Palomares; Ignacio García-Alonso
Journal:  Sci Rep       Date:  2021-03-08       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.